UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach

Frontiers in oncology, 2018-02, Vol.8, p.38-38

2018

Volltextzugriff (PDF)

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Clinical cancer research, 2015-10, Vol.21 (19), p.4327-4336

2015

Volltextzugriff (PDF)

Depletion of central memory CD8 + T cells might impede the antitumor therapeutic effect of Mogamulizumab

Nature communications, 2021-12, Vol.12 (1), p.7280-13, Article 7280

2021

Volltextzugriff (PDF)

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Oncotarget, 2016-11, Vol.7 (47), p.77404-77415

2016

Volltextzugriff (PDF)

Combination Cisplatin‐Epirubicin‐Paclitaxel Therapy for Metastatic Extramammary Paget's Disease

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.e394-e396

2019

Volltextzugriff (PDF)

AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma

The Journal of experimental medicine, 2021-09, Vol.218 (9)

2021

Volltextzugriff (PDF)

Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease

Journal of dermatology, 2017-10, Vol.44 (10), p.1148-1151

2017

Volltextzugriff (PDF)

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors

Cancer science, 2021-08, Vol.112 (8), p.3163-3172

2021

Volltextzugriff (PDF)

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

PloS one, 2023-09, Vol.18 (9), p.e0291772-e0291772

2023

Volltextzugriff (PDF)

Periostin Is a Key Niche Component for Wound Metastasis of Melanoma

PloS one, 2015-06, Vol.10 (6), p.e0129704-e0129704

2015

Volltextzugriff (PDF)

Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab

Journal of dermatological science, 2017-11, Vol.88 (2), p.225-231

2017

Volltextzugriff (PDF)

Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients

Journal of dermatology, 2023-02, Vol.50 (2), p.203-211

2023

Volltextzugriff (PDF)

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

Medical oncology (Northwood, London, England), 2021-04, Vol.38 (4), p.36-36, Article 36

2021

Volltextzugriff (PDF)

Unbiased Detection of Driver Mutations in Extramammary Paget Disease

Clinical cancer research, 2021-03, Vol.27 (6), p.1756-1765

2021

Volltextzugriff (PDF)

Successful management of tumor necrosis factor‐α inhibitor‐induced erythema multiforme by switching to a Janus kinase inhibitor in a patient with rheumatoid arthritis and ulcerative colitis

Journal of dermatology, 2023-04, Vol.50 (4), p.e117-e118

2023

Volltextzugriff (PDF)

Weekly docetaxel monotherapy for metastatic extramammary Paget’s disease: Retrospective single‐institute analysis

Journal of dermatology, 2020-04, Vol.47 (4), p.418-422

2020

Volltextzugriff (PDF)

Autoimmune and inflammatory diseases occur in cases of drug‐induced hypersensitivity syndrome but not in suspected cases

Journal of dermatology, 2021-01, Vol.48 (1), p.e45-e46

2021

Volltextzugriff (PDF)

Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer

Frontiers in medicine, 2019-07, Vol.6, p.160-160

2019

Volltextzugriff (PDF)

Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy

Cancer science, 2019-11, Vol.110 (11), p.3434-3441

2019

Volltextzugriff (PDF)

Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients

Journal of dermatology, 2023-02, Vol.50 (2), p.175-182

2023

Volltextzugriff (PDF)

Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk-Borne Maternal IgA

JAMA dermatology (Chicago, Ill.), 2021-09, Vol.157 (9), p.1107

2021

Volltextzugriff (PDF)

Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients

International journal of clinical oncology, 2021-12, Vol.26 (12), p.2338-2346

2021

Volltextzugriff (PDF)

Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis

Journal of investigative dermatology, 2018-07, Vol.138 (7), p.1473-1480

2018

Volltextzugriff (PDF)

Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients

Journal of dermatological science, 2018-01, Vol.89 (1), p.60-66

2018

Volltextzugriff (PDF)

Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan

Journal of dermatological science, 2018-12, Vol.92 (3), p.230-236

2018

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(110)
Berichte
(15)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Depletion of central memory CD8 + T cells might impede the antitumor therapeutic effect of Mogamulizumab

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Combination Cisplatin‐Epirubicin‐Paclitaxel Therapy for Metastatic Extramammary Paget's Disease

AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma

Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

Periostin Is a Key Niche Component for Wound Metastasis of Melanoma

Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab

Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

Unbiased Detection of Driver Mutations in Extramammary Paget Disease

Successful management of tumor necrosis factor‐α inhibitor‐induced erythema multiforme by switching to a Janus kinase inhibitor in a patient with rheumatoid arthritis and ulcerative colitis

Weekly docetaxel monotherapy for metastatic extramammary Paget’s disease: Retrospective single‐institute analysis

Autoimmune and inflammatory diseases occur in cases of drug‐induced hypersensitivity syndrome but not in suspected cases

Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer

Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy

Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients

Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk-Borne Maternal IgA

Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients

Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis

Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients

Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan

Suchergebnisse filtern